Mouwasat Medical Services stock

4002 · Tadawul · SAR

Compare Mouwasat Medical Services
SAR 56.50Change from previous close: −1.65%Absolute change: −SAR 0.95

Close · November 22, 2026

Price history

−20.14% over the period

1 year: from SAR 71.00 (November 23, 2025) to SAR 56.70 (November 22, 2026), −20.14%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 22, 2026SAR 56.70
October 29, 2026SAR 55.20
September 30, 2026SAR 61.45
August 31, 2026SAR 65.35
July 30, 2026SAR 62.20
June 30, 2026SAR 63.75
May 31, 2026SAR 65.35
April 30, 2026SAR 68.00
March 31, 2026SAR 72.65
February 26, 2026SAR 63.65
January 29, 2026SAR 69.60
December 31, 2025SAR 66.65
November 30, 2025SAR 68.00
November 23, 2025SAR 71.00

At a glance

  • The company

    Operates a network of hospitals and medical centers providing specialized healthcare services and pharmaceuticals across Saudi Arabia

  • Latest results

    Quarter to September 30, 2026 · EPS SAR 0.96 (estimate SAR 0.99)

TickerLandia's take on Mouwasat Medical Services

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk lowSAR 52.45
52-wk highSAR 73.95

−23.60% from the 52-week high

Analysts · 13 analysts

Average targetSAR 75.92+34.37% vs. price

Buy 6 · Hold 6 · Sell 1 · Buy

TickerLandia Fingerprint: Mouwasat Medical Services

Compared with similar companies: very high financial strength and very high profitability.

Financials and price compared with 19 companies in the medical care facilities industry, worldwide. Momentum and risk compared with 46 Middle Eastern stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Mouwasat Medical Services is cheaper than in the past and cheaper than similar companies

On the latest fiscal year's earnings (2025), Mouwasat Medical Services's P/E today is 13.8, below the median of its last 10 fiscal years (26.2; between 16.2 and 34.9 from 2016 to 2025). Mouwasat Medical Services's P/E (trailing 12 months): 13.5, −51% against the median of a group of 10 similar companies (27.7).

P/E compared with its history

Compared with 10 similar companies

Mouwasat Medical Services's metrics compared with similar companies
MetricMouwasat Medical ServicesPosition in the groupBand
P/E (trailing 12 months)13.5Middle
Forward P/E13.1Middle
Operating margin25.8%High
ROE21.2%High
Debt/equity0.29Low

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Mouwasat Medical Services. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

SAR 856.37M

Latest quarter · Q3 2026

Net income

SAR 188.01M

Latest quarter · Q3 2026

Quarterly net margin

22.0%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
SAR 11.49B
P/E
13.5
EPS
SAR 4.25
Volume
126.76K
Daily trading
€2.96M
Dividend yield
5.53%
Last ex-dividend on October 18, 2026

How Mouwasat Medical Services is changing

All results
  • Revenue grew 9.5% a year on average over the last 5 years

  • Operating margin fell from 28.8% to 27.3%

  • Profits turn into cash: free cash flow equal to 100% of net income

Returns

Mouwasat Medical Services returns with dividends

SAR 1,000 invested in Mouwasat Medical Services 5 years ago, on November 22, 2021, would be worth SAR 770 today with dividends reinvested: −23.01% in total, −5.10% per year. On price alone it would be SAR 687 (−31.27%).

PeriodMouwasat Medical ServicesSAR 1,000 becomes
1 month+2.16%SAR 1,022
6 months−14.59%SAR 854
Year to date−14.93%SAR 851
1 year−16.23%SAR 838
3 years−44.62%SAR 554
5 years−23.01%SAR 770
10 years+119.83%SAR 2,198

From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment

The chart in detail

Mouwasat Medical Services: technical analysis

Mouwasat Medical Services is in a downtrend: the price is below its 50- and 200-session moving averages, and the 200-session average is falling. The price is 60.3% below its all-time closing high (SAR 142.40, April 21, 2024).

Trend
Downward
RSI (14 sessions)
44
Between 30 and 70
vs 200-session average
−11.96%

Support and resistance

Price areas where Mouwasat Medical Services has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. ResistanceSAR 64.40+13.98%3 touches, last on June 11, 2026
  2. ResistanceSAR 60.92+7.83%2 touches, last on October 1, 2026
  3. ResistanceSAR 59.55+5.40%2 touches, last on November 15, 2026
  4. Last priceSAR 56.50
  5. SupportSAR 52.75−6.64%2 touches, last on November 3, 2026

Volatility and risk

Volatility (60 sessions, annualised)
23.8%
Largest fall in the last year
−27.33%

Close of November 22, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Mouwasat Medical Services: seasonality

Average monthly price change over 18 years

+0.1%Jan+0.8%Feb+5.3%Mar+5.4%Apr−1.6%May+1.9%Jun+4.6%Jul−2.6%Aug−1.9%Sep−0.1%Oct−0.9%Nov+4.1%Dec

Over the last 18 years, the strongest month for Mouwasat Medical Services has been April: +5.43% on average, positive in 13 years out of 17. The weakest has been August: −2.64% on average, positive in 6 years out of 17. November, the current month, has been positive in 8 years out of 17 (−0.94% on average).

Show chart data
MonthAverageMedianPositive years
January+0.15%−2.04%7 of 17
February+0.84%+1.46%10 of 17
March+5.31%+4.25%11 of 17
April+5.43%+5.02%13 of 17
May−1.60%−1.51%8 of 17
June+1.87%0.00%8 of 17
July+4.61%+0.73%11 of 17
August−2.64%−4.88%6 of 17
September−1.92%−2.12%7 of 17
October−0.08%+0.19%9 of 18
November−0.94%0.00%8 of 17
December+4.09%+6.53%12 of 17

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Mouwasat Medical Services and its competitors

Patients across Saudi Arabia form the core customer base of Mouwasat Medical Services Company, which runs a network of hospitals and specialized centers for eye care, obesity treatment, cardiology, diabetes, robotic surgery, fertility, rehabilitation, long-term care, stroke and skincare. Its services also include inpatient pharmacy, intravenous medication preparation, chemotherapy preparation and clinical pharmacy.

Headquarters
Dammam, Saudi Arabia
Employees
2,389
Founded
1974
Chief executive
Nasser Sultan Al-Subaie
Mouwasat Medical Services and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Mouwasat Medical Services4002$3.16B25.8%13.5−14.59%
Dr. Sulaiman Al Habib Medical Services Group4013$20.02B18.6%29.1−6.43%
MedicoverMCOV.B$3.82B7.4%38.3+19.86%
Fortis HealthcareFORTIS$6.47B17.1%56.8−15.35%
Spire Healthcare GroupSPI$1.3B7.6%—+12.90%
Ramsay Health CareRHC$8.37B5.9%40.0+40.77%

Same industry or related industries, similar size. Compare Mouwasat Medical Services with its competitors · Full profile